Uses of Misomato 5

Misopato 5 belongs to the group of cardiovascular drugs that help treat chronic heart failure and high blood pressure. The drug has the active ingredient Bisoprolol fumarate 5mg as the active ingredient. Misopato 5 is prepared in the form of film-coated tablets packed in boxes of 3 blisters x 10 tablets. Let's find out more details about the uses and how to use Misomato 5 most effectively through the article below.

Misopato 5 medicine containing the active ingredient Bisoprolol fumarate (belonging to the group of selective beta-blockers) is indicated for use in the following cases:
Treatment of high blood pressure. Treatment of coronary artery disease in the form of angina. Treatment of stable chronic heart failure and impaired left ventricular systolic function is combined with diuretics, ACE inhibitors, and cardiac glycosides.

Misomato 5 is used orally. Patients should take the tablet whole with water, do not chew the tablet because it can reduce the effect. The best time to take the medicine is before or after breakfast.
The dose of the drug will depend on the medical condition and the user, which will have the most appropriate dose of Misopato 5.
Treatment of coronary heart disease and high blood pressure:
Dosage will be adjusted for each patient and based on heart rate and treatment results. The initial dose is usually 5mg Bisoprolol fumarate 1 time / day (1 tablet). If mild hypertension with diastolic blood pressure of about 105 mmHg, dose with 2.5 mg once/day (1⁄2 tablets) If necessary, the dose can be increased to 10mg Bisoprolol fumarate/time/day (2 tablets) ). The maximum dose is 20 mg Bisoprolol fumarate / 1 time / day (4 tablets). Treatment of stable chronic heart failure:
Standard treatment regimens for chronic heart failure include ACE inhibitors (or angiotensin receptor blockers when ACE inhibitors are not tolerated), diuretics, and blockers. beta and with cardiac glycosides.
When using Misopato 5 for the treatment of stable chronic heart failure, a special examination period is required and regular medical supervision is required. The treating physician should have extensive experience in the treatment of chronic heart failure.
The following is a regimen for the treatment of stable heart failure with Misopato 5:
Week 1: Use a dose of 1.25 mg of Bisoprolol fumarate once a day, which can be increased if well tolerated. Week 2: Dose of 2.5 mg Bisoprolol fumarate once/day (1⁄2 tablets), can be increased if well tolerated. Week 3: Use 3.75 mg Bisoprolol fumarate once/day, can be increased if well tolerated. Weeks 4-7: Bisoprolol fumarate 5mg once a day (1 tablet) can be increased if well tolerated. Weeks 8-11: Dose of 7.5 mg Bisoprolol fumarate once daily (1⁄2 tablets), may be increased if well tolerated. Week 12 and beyond: Use 10 mg of Bisoprolol fumarate once a day (2 tablets) as a maintenance dose. The maximum dose is 10 mg Bisoprolol/time/day. In addition, patients should be monitored and maintained at this dose level unless this is not possible due to adverse effects. Closely monitor blood pressure, heart rate, and signs of worsening heart failure during the titration phase. During the titration phase or after the dose adjustment, if transient worsening of heart failure, bradycardia or hypotension occurs, the dosage of concomitant medications should be reviewed. Temporarily reduce dose of Bisoprolol or consider discontinuing Bisoprolol treatment if necessary. Re-initiation of Bisoprolol or an increase in dose should always be considered when the patient is stable again.

Misopato 5 drugs should not be used in the following cases:
Patients with allergies, hypersensitivity to Bisoprolol or any ingredient of the drug. Acute heart failure, decompensated heart failure requiring intravenous infusion of inotropic drugs. Shock due to cardiac dysfunction. Atrioventricular block II, III Sinus node failure syndrome Sinus atrial block Bradycardia Low blood pressure Severe bronchial asthma Peripheral artery occlusion Raynaud's syndrome Untreated adrenal tumor Metabolic acidosis Concurrent use with MAOIs

Misopato 5 combined with the following drugs can occur drug interactions:
Cardiovascular drugs MAO drugs Clonidine drugs Antiarrhythmic drugs Antidiabetic drugs Digitalis drugs Pain relievers & anti-inflammatory drugs Ergotamine Sympathomimetic drugs Antiepileptic drugs Psychotropic drugs Rifampicin drugs Mefloquin drugs To ensure safety, patients should inform their doctor, pharmacist of all the drugs they are using.

During the treatment of Misopato 5, patients may experience some unwanted effects such as:
Cold feeling, numbness of limbs Digestive disorders Fatigue, dizziness Muscle weakness Symptoms cramps Sleep disorders Asthenia,...

Misopato 5 should be used with caution in patients with Prinzmetal's chest pain, heart failure, first-degree atrioventricular block, lung disease, diabetes, renal or hepatic failure, psoriasis, peripheral arterial embolism, hyperthyroidism, valvular disease heart disease, cardiomyopathy.
Use caution on the elderly, children, pregnant & lactating women, drivers & machine operators.